CSF3 and neoplasm: Our data suggested that the IRE1α kinase inhibitor APY29, which could block the upregulation of G-CSF and GM-CSF in glutamine deprived tumor cells in vitro, might be an option for future studies to reduce the mobilization and generation of MDSC.